CTX Statistics

Total Valuation

Captor Therapeutics Spolka Akcyjna has a market cap or net worth of PLN 240.60 million. The enterprise value is 197.31 million.

Market Cap	240.60M
Enterprise Value	197.31M

Important Dates

The next estimated earnings date is Thursday, November 28, 2024.

Earnings Date	Nov 28, 2024
Ex-Dividend Date	n/a

Share Statistics

Captor Therapeutics Spolka Akcyjna has 4.66 million shares outstanding. The number of shares has increased by 18.85% in one year.

Current Share Class	n/a
Shares Outstanding	4.66M
Shares Change (YoY)	+18.85%
Shares Change (QoQ)	-0.29%
Owned by Insiders (%)	36.74%
Owned by Institutions (%)	22.97%
Float	2.71M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	13.30
PB Ratio	5.85
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-4.79
EV / Sales	10.19
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-4.79

Financial Position

The company has a current ratio of 2.65, with a Debt / Equity ratio of 0.13.

Current Ratio	2.65
Quick Ratio	2.65
Debt / Equity	0.13
Debt / EBITDA	n/a
Debt / FCF	-0.13
Interest Coverage	-123.90

Financial Efficiency

Return on equity (ROE) is -100.45% and return on invested capital (ROIC) is -56.74%.

Return on Equity (ROE)	-100.45%
Return on Assets (ROA)	-38.05%
Return on Capital (ROIC)	-56.74%
Revenue Per Employee	184,343
Profits Per Employee	-391,924
Employee Count	105
Asset Turnover	0.28
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -39.45% in the last 52 weeks. The beta is 0.57, so Captor Therapeutics Spolka Akcyjna's price volatility has been lower than the market average.

Beta (5Y)	0.57
52-Week Price Change	-39.45%
50-Day Moving Average	69.77
200-Day Moving Average	76.43
Relative Strength Index (RSI)	19.96
Average Volume (20 Days)	1,927

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Captor Therapeutics Spolka Akcyjna had revenue of PLN 19.36 million and -41.15 million in losses. Loss per share was -8.25.

Revenue	19.36M
Gross Profit	11.04M
Operating Income	-41.75M
Pretax Income	-41.15M
Net Income	-41.15M
EBITDA	-31.08M
EBIT	-41.75M
Loss Per Share	-8.25

Full Income Statement

Balance Sheet

The company has 48.82 million in cash and 5.52 million in debt, giving a net cash position of 43.30 million or 9.29 per share.

Cash & Cash Equivalents	48.82M
Total Debt	5.52M
Net Cash	43.30M
Net Cash Per Share	9.29
Equity (Book Value)	41.11M
Book Value Per Share	8.82
Working Capital	34.38M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -40.92 million and capital expenditures -236,000, giving a free cash flow of -41.16 million.

Operating Cash Flow	-40.92M
Capital Expenditures	-236,000
Free Cash Flow	-41.16M
FCF Per Share	-8.83

Full Cash Flow Statement

Margins

Gross margin is 57.02%, with operating and profit margins of -215.71% and -212.61%.

Gross Margin	57.02%
Operating Margin	-215.71%
Pretax Margin	-212.61%
Profit Margin	-212.61%
EBITDA Margin	-160.55%
EBIT Margin	-215.71%
FCF Margin	-212.64%

Dividends & Yields

Captor Therapeutics Spolka Akcyjna does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-18.85%
Shareholder Yield	-18.85%
Earnings Yield	-15.99%
FCF Yield	-17.11%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Captor Therapeutics Spolka Akcyjna has an Altman Z-Score of 4.66.

Altman Z-Score	4.66
Piotroski F-Score	n/a